Mestinon and Hydrocortisone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mestinon (pyridostigmine bromide) and Hydrocortisone (hydrocortisone). Common drug interactions include fatigue among females.

The phase IV clinical study analyzes what interactions people have when they take Mestinon and Hydrocortisone. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Mestinon?

Mestinon has active ingredients of pyridostigmine bromide. It is often used in myasthenia gravis. eHealthMe is studying from 5,948 Mestinon users. Check the latest studies of Mestinon.

What is Hydrocortisone?

Hydrocortisone has active ingredients of hydrocortisone. It is often used in addison's disease. eHealthMe is studying from 40,425 Hydrocortisone users. Check the latest studies of Hydrocortisone.



On Jul, 05, 2026

39 people who take Mestinon and Hydrocortisone together, and have interactions are studied.

Mestinon and Hydrocortisone drug interactions.

What are the common drug interactions of Mestinon and Hydrocortisone, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Sinusitis (inflammation of sinus)
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Conjunctivitis (pink eye)
  5. Diarrhoea
  6. Nail infection
  7. Nausea (feeling of having an urge to vomit)
  8. Vomiting
  9. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  10. Infusion site bruising

male:

n/a

What are the common drug interactions of Mestinon and Hydrocortisone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Pain in extremity
  2. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  3. Peripheral swelling
  4. Poor peripheral circulation
  5. Pulmonary embolism (blockage of the main artery of the lung)
  6. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  7. Sjogren's syndrome (a disease that causes dryness in the mouth and eyes)
  8. Urinary tract infection
  9. Vomiting
  10. Weight increased

40-49:

  1. Blood glucose increased
  2. Blood pressure increased
  3. Chills (felling of cold)
  4. Concussion (short loss of normal brain function in response to a head injury)
  5. Escherichia test positive
  6. Fall
  7. Haematoma (collection of blood outside the blood vessels)
  8. Hypotension (abnormally low blood pressure)
  9. Infusion related reaction
  10. Upper respiratory tract infection

50-59:

  1. Jaundice cholestatic
  2. Oedema peripheral (superficial swelling)
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  4. Dehydration (dryness resulting from the removal of water)
  5. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  6. Fatigue (feeling of tiredness)
  7. Headache (pain in head)
  8. Hordeolum (small collection of pus (abscess) on the eyelid)
  9. Joint stiffness
  10. Post procedural infection

60+:

  1. Diarrhoea
  2. Lung disorder (lung disease)
  3. Erythema (redness of the skin)
  4. Fatigue (feeling of tiredness)
  5. Femur fracture
  6. Hereditary angioedema (recurrent episodes of severe swelling)
  7. Hypersensitivity
  8. Infusion site pain
  9. Multiple allergies (allergy to multiple agents)
  10. Rash

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 12 people, 30.77%
  2. Humoral Immune Defect (impairment of humoral immunity): 5 people, 12.82%
  3. Polymyositis (inflammatory muscle disease that causes weakness of the skeletal muscles): 3 people, 7.69%
  4. Osteopenia (a condition where bone mineral density is lower than normal): 3 people, 7.69%
  5. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 7.69%
  6. Lambert-Eaton Syndrome (this means your immune system mistakenly targets healthy cells and tissues in the body): 3 people, 7.69%
  7. Immune System Disorder: 3 people, 7.69%
  8. Restless Leg Syndrome (a powerful urge to move your legs): 2 people, 5.13%
  9. Multiple Myeloma (cancer of the plasma cells): 2 people, 5.13%
  10. Drowsiness: 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Mestinon and Hydrocortisone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mestinon and Hydrocortisone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mestinon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hydrocortisone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mestinon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydrocortisone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pyridostigmine bromide and hydrocortisone (the active ingredients of Mestinon and Hydrocortisone, respectively), and Mestinon and Hydrocortisone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: